Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Payables (2020 - 2025)

Historic Payables for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to $3.4 million.

  • RxSight's Payables fell 2628.25% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year decrease of 2628.25%. This contributed to the annual value of $4.5 million for FY2024, which is 1762.88% up from last year.
  • Latest data reveals that RxSight reported Payables of $3.4 million as of Q3 2025, which was down 2628.25% from $3.3 million recorded in Q2 2025.
  • In the past 5 years, RxSight's Payables ranged from a high of $7.1 million in Q1 2025 and a low of $1.7 million during Q4 2021
  • Its 5-year average for Payables is $3.7 million, with a median of $3.8 million in 2023.
  • As far as peak fluctuations go, RxSight's Payables soared by 14671.79% in 2022, and later crashed by 3428.85% in 2025.
  • RxSight's Payables (Quarter) stood at $1.7 million in 2021, then surged by 53.64% to $2.6 million in 2022, then skyrocketed by 48.86% to $3.9 million in 2023, then grew by 17.63% to $4.5 million in 2024, then fell by 25.68% to $3.4 million in 2025.
  • Its last three reported values are $3.4 million in Q3 2025, $3.3 million for Q2 2025, and $7.1 million during Q1 2025.